All osseous metastases in the G12C KRAS group were lytic in contrast to the higher frequency of sclerotic metastasis in the RET+, ROS1+, and ALK+ NSCLC groups [10,17,27]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.